This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Ana Beatriz Korngold: Innovator in Chimeric Antigen Receptors
Introduction
Ana Beatriz Korngold is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CAR). With a total of 2 patents, her work is paving the way for advancements in cancer treatment and immunotherapy.
Latest Patents
Ana Beatriz Korngold's latest patents focus on the methods of generating chimeric antigen receptors. These patents provide innovative methods for library screening of CAR by generating a vector encoding the CAR from random attachment of vectors from libraries of vectors encoding antigen-binding domains, hinge regions, and endodomains. In some embodiments, the vectors contain a transposon, enhancing the efficiency of CAR development.
Career Highlights
Ana is affiliated with the University of Texas System, where she continues to push the boundaries of research in her field. Her work has garnered attention for its potential applications in treating various forms of cancer, showcasing her dedication to improving patient outcomes through innovative technology.
Collaborations
Ana collaborates with notable colleagues, including Simon Olivares and Harjeet Singh. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field of immunotherapy.
Conclusion
Ana Beatriz Korngold is a trailblazer in the development of chimeric antigen receptors, with her innovative patents and collaborative efforts marking her as a key figure in biotechnology. Her contributions are vital to the future of cancer treatment and immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
